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DCs express receptors sensing microbial, danger or cytokine signals, which when
triggered in combination drive DC maturation and functional polarization. Maturation
was proposed to result from a discrete number of modifications in conventional DCs
(cDCs), in contrast to a cell-fate conversion in plasmacytoid DCs (pDCs). cDC matura-
tion is generally assessed by measuring cytokine production and membrane expression
of MHC class II and co-stimulation molecules. pDC maturation complexity was demon-
strated by functional genomics. Here, pDCs and cDCs were shown to undergo profound
and convergent changes in their gene expression programs in vivo during viral infection.
This observation was generalized to other stimulation conditions and DC subsets, by
public microarray data analyses, PCR confirmation of selected gene expression profiles,
and gene regulatory sequence bioinformatics analyses. Thus, maturation is a complex
process similarly reshaping all DC subsets, including through the induction of a core set
of NF-κB- or IFN-stimulated genes irrespective of stimuli.
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Introduction
DCs are specialized in the processing of peptide antigens and their
presentation in association with MHC molecules for the activa-
tion of na¨ıve T lymphocytes [1]. DCs contribute to preventing
autoimmunity by inducing tolerance to self-antigens while pro-
moting immunity against pathogens and cancer. DCs expressmany
innate immune recognition receptors that allow them to sense
and integrate microbial, danger, or cytokine signals early during
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infection or tumorigenesis. During this activation process, DCs
undergomorphological, phenotypical, and functional changes that
are globally referred to as maturation [2]. Mature DCs deliver
three kinds of output signals to T cells: (i) cognate engagement
of the TCR by MHC+peptide complexes, (ii) engagement of co-
receptors by co-stimulation molecules, and (iii) cytokines. Dif-
ferent input signals received by DCs determine the delivery of
distinct output signals to T cells which determine their functional
polarization [2].
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An additional layer of complexity to the functional plasticity
of DCs is the existence of different DC subsets that express dis-
tinct arrays of innate immune recognition receptors and are spe-
cialized in different activities [3]. Five major DC subsets exist in
mice: plasmacytoid DCs (pDCs), CD8α+-type conventional DCs
(cDCs), CD11b+-type cDCs, monocyte-derived DCs (MoDCs), and
Langerhans cells [3]. Equivalent DC subsets exist in humans
[4–10]. pDCs are major producers of the antiviral cytokines type
I interferons (IFNs-I) in response to many, although not all, viral
infections [11]. CD8α+-type cDCs encompass lymphoid-tissue res-
ident CD8α+ DCs and the CD103+CD11b− DCs residing in non-
lymphoid tissues but able to migrate to draining lymph nodes
upon maturation [12–15]. They are especially efficient for CD8+
T-cell activation, including through antigen cross-presentation
and IL-12 production, hence playing a major role in the induc-
tion of cellular adaptive immune responses against intracellu-
lar pathogens and tumors [3, 15]. CD11b+-type cDCs encompass
lymphoid-tissue resident CD11b+ DCs and nonlymphoid tissue
CD11b+CD207− DCs [15]. They are endowed with a high capac-
ity for CD4+ T-cell activation and promotion of humoral immu-
nity. pDCs, CD8α+-type cDCs, and CD11b+-type cDCs constitute
a specific lineage of hematopoietic cells derived from a common
DC progenitor and depend on the growth factor FLT3-L [15].
In contrast, Langerhans cells and MoDCs belong to the mono-
cyte/macrophage lineage and depend on the growth factors
GM-CSF or M-CSF [16, 17] and IL-34 [18], respectively. In vivo
inflammation induces the development of a DC subset equiva-
lent to the MoDCs derived in vitro from monocytic precursors in
the presence of GM-CSF [10, 16]. It participates both in direct
anti-microbial defense and in adaptive immunity induction [3],
especially Th17 induction [10].
Hence, DC maturation must be tightly regulated both by DC
subset-intrinsic properties and by the microenvironment in which
the cells reside. DC maturation cannot be characterized fully
by the measurement of a few parameters, as is generally per-
formed by examining MHC class II molecule export to plasma
membrane, co-stimulation molecule upregulation and cytokine
production. Large-scale and unbiased approaches should help to
better understand the molecular events associated with DC matu-
ration, similar to the advances these approaches brought forward
in the characterization of steady-state or inflammatory DC subsets
[4, 9, 10, 14, 19, 20]. Many studies have harnessed the power
of gene expression profiling to study the activation of in vitro-
derived mouse or human MoDCs, for example to decipher the
transcriptional networks mediating their responses to virus-type
versus bacterial-type stimuli [21], to investigate kinetically how
the induction of their antiviral activity is orchestrated by a network
of transcription factors [22] or to examine differences in responses
to commensal versus pathogenic fungi [23]. Gene expression pro-
filing has also been used to characterize how the artificial loss of
the transcription factor TCF4 (E2–2) affects pDC [24]. A major
reshaping of pDC gene expression program occurred upon loss of
E2–2 expression, associated to the acquisition of cDC character-
istics and of canonical signs of maturation as occurs upon pDC
activation by viral-type stimuli [25, 26]. Based on these studies,
pDCs and cDCs were proposed to fundamentally differ in their
physiological responses to activation, pDCs undergoing “a true
cell-fate conversion” by differentiating into cDCs as a consequence
of a spontaneous decrease in E2–2 expression, while cDCs were
thought to be subject to fewer and more subtle changes quali-
fied as “mere maturation” [27]. Yet, it is not known whether a
true cell-fate conversion of pDCs into cDCs happens under physi-
ological conditions in vivo during a viral infection. Moreover, the
extent of the global changes that pDCs and cDCs undergo under
the same activation conditions has not been compared. Hence, it is
difficult to conclude that activation leads to fundamentally differ-
ent consequences for pDCs and cDCs. Therefore, we engaged into
characterizing how a single physiological perturbation causing the
maturation of pDC and cDC in vivo impacts their gene expression
programs.
We chose to use mouse cytomegalovirus (MCMV) infection as
a working model, because (i) it allows studying the interactions
between a virus and its natural host while recapitulating many
physiopathological characteristics of the equivalent infection in
humans [28], (ii) it leads to the activation of all spleen DC subsets
early after intraperitoneal infection, and (iii) all DC subsets con-
tribute to the induction of host immune defenses. We discovered
that both pDCs and cDCs undergo profound changes in vivo upon
viral infection, encompassing a striking convergence of their gene
expression programs through common modulation of hundreds of
transcripts.
FLT3-L-dependent DC subsets are now widely accepted to
be the most important cell types for the initiation of immune
responses in vivo, due to their location in, or efficient migration
to, lymph nodes, in contrast to MoDCs which are not present in
lymphoid organs under steady-state conditions or only at very
low levels and which do not migrate efficiently to lymph nodes
[29]. It is therefore critical to better understand the molecular
mechanisms that regulate the functions of FLT3-L-dependent DC
subsets. To contribute to this aim, we provide here data on the
gene expression reprogramming of FLT3-L-dependent DC subsets
upon their maturation in response to a physiological stimulus.
Except for the characterization of the gene expression program
of lung CD103+CD11b− DCs from mice injected with polyI:C as
performed by the Immgen consortium [20], we are not aware of
public data on the gene expression profiling of FLT3-L-dependent
cDC subsets under microbial-type stimulation conditions, and
assuredly not in a context where both cDC subsets and pDCs are
studied in parallel. Hence, it was not known to which extent the
maturations of pDCs, of FLT3-L-dependent cDCs and of MoDCs
were similar, beyond their upregulation of co-stimulation and
MHC molecules. We took advantage of our study to address
this question by comparing our data with data freely available
on public databases, in order to extend our analysis to a vari-
ety of stimulation conditions and to other mouse and human DC
subsets. We identified, for the first time to the best of our knowl-
edge, a core set of NF-κB- or IFN-stimulated genes induced in DCs
upon their maturation irrespective of the stimulus they received,
irrespective of the subset they belong to, and conserved in
evolution.
C© 2013 The Authors. European Journal of Immunology published by
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Results
Mouse cytomegalovirus (MCMV) infection causes a
convergent activation of all spleen DC subsets in vivo
To assess the general impact of MCMV infection on DC subsets
early after virus inoculation, we profiled the gene expression pro-
grams of splenic pDCs, CD8α+ cDCs, and CD11b+ cDCs isolated
from control animals (q cell = quiescent cell) or MCMV-infected
mice (a cell = activated cell). We also included NK cells and
B lymphocytes from control versus MCMV-infected animals, and
T lymphocytes from control mice. To determine the overall prox-
imity between the cell types isolated fromMCMV-infected animals
and control mice, we ran an unsupervised hierarchical cluster-
ing on the genes that showed at least a twofold change in their
expression level across all cell types (Fig. 1A). Two main clusters
were obtained: one composed by DCs and the other by lymphoid
cells. a B cells and a NK cells closely associated with their quies-
cent counterparts, each of this two lineages constituting a distinct
branch within the lymphoid cell cluster irrespective of the activa-
tion status of the cells. In contrast, a DC subsets clustered together,
apart from q DCs. Thus, profound and convergent changes in the
gene expression programs of all three splenic DC subsets occurred
in vivo early after MCMV infection. Indeed, principal component
(PC) analysis showed that “activation versus quiescence” (PC1
axis) and “pDC-ness versus cDC-ness” (PC2 axis) accounted for a
similar fraction of the overall variability between the microarrays,
respectively 36 and 30% (Fig. 1B). Hence, both the belonging to
a given subset and the activation status contributed strongly and
equally to the shaping of the gene expression programs of mature
DC subsets.
Activated spleen DC subsets maintain their identity
during MCMV infection
We investigated whether each a DC subset maintained its iden-
tity despite their convergent genetic reprograming (Fig. 1C).
We previously identified sets of genes specifically expressed in
each spleen q DC subset [4] and addressed here whether these
transcriptomic fingerprints were maintained upon activation. We
performed Gene Set Enrichment analyses (GSEA) [30] on pair-
wise comparisons of DC subsets. We generated the control pat-
terns of q DC subset comparisons (Fig. 1C, ) and the patterns
of a DC subset comparisons (Fig. 1C, ). The two figures look
remarkably similar, showing that each a DC subset maintained
the transcriptomic fingerprint initially defined in its q DC subset
counterpart. Hence, despite the profound and common changes
in gene expression that all DC subsets undergo during MCMV
infection in vivo, each activated subset keeps track of its spe-
cific lineage through maintained selective expression of a tran-
scriptomic fingerprint, as further illustrated with individual gene
expression profiles (Supporting Information Fig. 1A). In partic-
ular, pDCs did not undergo a cell-fate conversion into cDCs at
A
C
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Figure 1. MCMV infection leads to a profound and convergent genetic
reprogramming of all splenic DC subsets in vivo. Genome-wide expres-
sion analysis was performed on quiescent (q) versus activated (a)
immune cells isolated from the spleen of untreated versus d1.5 MCMV-
infected C57BL/6 mice. (A) Unsupervised hierarchical clustering of
splenocyte subsets from control or MCMV-infected animals was per-
formed. Unsupervised hierarchical clustering with complete linkage
was performed on the 28 707 ProbeSets selected as having at least one
Log2 expression value >5 in the dataset and a fold change >2 across
all conditions. Boxes highlight clusters of q_DC subsets (gray) versus
a_DC subsets (black). (B) Principal component analysis on all Probe-
Sets present on the microarrays. (C) DC subsets maintain their identity
after activation. GSEA was performed using previously published sets
of genes corresponding to the transcriptional fingerprints of q_DC sub-
sets as compared with many other leukocytes [4] or corresponding to
the genes up or downregulated in the pDC of E2–2 knock-out mice [32].
Pair-wise comparisons were performed to assess enrichment of the
GeneSets betweenq_DC subsets as a control,a_DC subsets isolated
from d1.5 MCMV-infected mice, and  q_DC subsets and their a_DC
subset counterparts. Results are represented as circular symbols, the
size and intensity of color increasing as the enrichment was stronger
andmore significant, in a colormatching that of the cell subset inwhich
the GeneSet was enriched. Specifically, the circle surface area is propor-
tional to the absolute value of the normalized enrichment score, which
varies between ∼1 (no enrichment) and ∼5 (best enrichment possible).
The color intensity of circles is indicative of the false-discovery rate
statistical q value. Data shown are from two independent replicates
from two different experiments except for q_B cells where triplicates
were performed and a_B cells where only a singlet experiment was
performed.
C© 2013 The Authors. European Journal of Immunology published by
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36 hours after MCMV infection at a time when these cells were
very close to their maximal upregulation of co-stimulation and
MHC class II molecules [31] and when a fraction of them had
readily developed dendrites [26].
Activation downmodulates DC subset expression of
their steady-state transcriptomic fingerprint
A comparison of each a DC subset with its q DC subset counter-
part showed a clear downmodulation of the DC subset-specific
transcriptomic fingerprints upon activation (Fig. 1C,  and Sup-
porting Information Fig. 1B). This was not only true for pDCs
as predicted [24], but also for CD8α+ cDCs and CD11b+ cDCs.
In addition, the cDC GeneSet was upregulated in a pDCs as com-
paredwith q pDCs (Fig. 1C,, Supporting Information Fig. 1C and
2), and the pDC GeneSet was upregulated in a CD8α+ cDCs and
a CD11b+ cDCs as compared with their quiescent counterparts
(Fig. 1C,, Supporting Information Fig. 1D and 3), contributing
to the convergence observed between a pDCs and a cDCs in the
hierarchical clustering (Fig. 1A). For many genes of the cDC Gene-
Set, a strong induction was observed in a pDCs to expression levels
similar to those observed in q cDCs. However, a significant induc-
tion also occurred in cDCs leading to expression levels in a cDCs
significantly above those observed in q cDCs and a pDCs (Support-
ing Information Fig. 1C, Cxcl9, Marcksl1, Cd86, A630077B13Rik,
Vcam1, Traf1, Etv3, and Aim1). Of note, Stx11 and Trafd1 were
strongly induced to the same levels in all DC subsets. Some of the
genes that were expressed at higher levels in steady-state pDCs
were induced to similar or even higher levels in cDCs upon acti-
vation (Irf7, Ly6a, Snn, and Rilpl1) or were inversely regulated in
a pDCs and a cDCs (Sema4c and Serinc5) (Supporting Information
Fig. 1D). However, most of the pDC-specific genes induced in acti-
vated cDCs based on GSEA kept much higher levels of expression
in pDCs as compared with a cDCs (as illustrated with Dirc2, Igkc,
Ly6c1, Ctsl, Blnk, and Klk1 in Supporting Information Fig. 1D). A
similar genetic reprogramming occurs in pDCs when they mature
after having undergone artificial conditional genetic inactivation
of E2–2 [32]. Therefore, we examined whether the genes known
to be regulated by E2–2 in pDCs were affected in DC subsets
during their physiological maturation induced by MCMV infec-
tion of mice. The “E2–2-repressed GeneSet” regroups the genes
induced in pDCs upon genetic inactivation of E2–2 expression
[32]. The “E2–2-induced” GeneSet regroups the genes inhibited
in pDCs upon the conditional knock-out of E2–2 [32]. Consistent
with their natural downregulation of E2–2 (Supporting Informa-
tion Fig. 1B), a pDCs showed a significant increase in the expres-
sion of the “E2–2-repressed” GeneSet, and, reciprocally, a signif-
icant decrease in the expression of the “E2–2-induced” GeneSet
(Fig. 1C, and Supporting Information Fig. 1E and F). Strikingly,
the “E2–2-repressed” GeneSet was also significantly upregulated
in a CD8α+ cDCs as compared with their quiescent counterpart
(Fig. 1C, , and Supporting Information Fig. 1E), while CD8α+
cDCs do not express significant levels of E2–2 (Supporting Infor-
mation Fig. 1B). Interestingly, while the “E2–2-repressed” Gene-
A
C
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Figure 2. Hundreds of genes are similarly modulated in a_DC subsets
as compared with their q_DC subset counterparts. (A and B) The Venn
diagrams represent the number of ProbeSets significantly (A) upreg-
ulated or (B) downregulated >twofold in a_DC subsets from MCMV-
infected mice as compared with their q_DC subset counterparts. (C and
D) The heatmaps represent selected functions and pathways found
enriched by Ingenuity Pathway Analysis for the sets of genes depicted
in the Venn diagrams. The color scale indicates the significance of the
enrichment, from white (not enriched) to red (enriched). The data ana-
lyzed are the same as in Figure 1.
Set was globally downregulated in a CD11b+ cDCs as compared
with their quiescent counterpart (Fig. 1C,), a few of the genes
it encompasses were on the contrary induced to high levels in
a CD11b+ cDCs as they were in a pDCs and in a CD8α+ cDCs.
This included genes involved in biological processes linked to DC
maturation such as dendrite formation for Fscn1 or cross-talk with
CD4+ T cells for Cd40 (Supporting Information Fig. 1E). This con-
tributed to the convergence observed between a pDCs and a cDCs
in the hierarchical clustering. Hence, not only pDCs but also cDCs
C© 2013 The Authors. European Journal of Immunology published by
Wiley-VCH Verlag GmbH & Co. KGaA Weinheim.
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downregulate their steady-state transcriptomic fingerprint during
viral infection in vivo and upregulate common maturation genes
from the “E2–2-repressed” and “cDC” GeneSets, although this may
occur in part through different molecular switches in distinct DC
subsets.
Hundreds of genes are modulated in all DC subsets
during MCMV infection
To compare more precisely how MCMV infection modulates the
gene expression program of each of the cell types examined, we
identified the ProbeSets that were significantly induced or inhib-
ited≥twofold in a DC subsets with respect to their quiescent coun-
terparts. We determined the overlaps between these lists (Fig. 2A
and B). 541 Probesets (representing 410 genes) were induced,
and 237 ProbeSets (representing 199 genes) were inhibited, com-
monly in all three DC subsets. Hence, hundreds of genes are com-
monly modulated in all DC subsets during MCMV infection. Rel-
atively large groups of Probesets were specifically modulated in
each DC subset, consistent with the fact that they differed in their
capacity to exert specific functions, such as IFN-I production which
was much higher in pDCs or IL-15/IL-15Rα expression which was
much higher in CD8α+ cDCs [11]. We examined the annotations
of the different groups of genes co-regulated in a DC subsets,
using Ingenuity Pathway Analysis. The most significant functions
and pathways found were associated with the genes induced in
all a DC subsets and linked to inflammation, DC maturation, viral
sensing, IFN-I induction or signaling, and communication between
DCs and NK or T cells (Fig. 2C and D), confirming that, in all
DC subsets, maturation significantly enhanced functions critical
for cell-intrinsic antiviral defenses and for induction of adaptive
immunity.
A core gene signature is associated with DC
maturation upon activation by microbial-type stimuli
To test whether the extensive genetic reprogramming of mouse
spleen DC subsets observed during MCMV infection could be gen-
eralized to other conditions of activation, we examined the expres-
sion pattern of a selection of these genes by PCR arrays in different
mouse DC subsets upon various stimulations. The transcriptional
modulation of these genes during DCmaturationwas not only con-
firmed in DC subsets from MCMV-infected mice but also extended
to all the other conditions tested (Fig. 3). For further general-
ization, we analyzed a number of independent public microarray
data encompassing gene expression profiling of different mouse or
human DC subsets in response to a variety of microbial-type stim-
uli (Table 1). Specifically, we performed GSEA using as GeneSets
the lists of genes modulated in DC subsets during MCMV infection
as described in Fig. 2A and B. Strikingly, a significant proportion
of the genes modulated in mouse spleen DCs during MCMV infec-
tion followed the same pattern of regulation upon DC activation in
each of the other conditions examined (Fig. 4). Altogether, when
Figure 3. Confirmation of the expression profiles of selected genes by
PCR array. The expression pattern of 40 genes upregulated and eight
genes downregulated in all splenic DC subsets during MCMV infection
as assessed by microarrays was confirmed on independent samples by
PCR-array and extended to five other conditions combining different DC
subsets (CD8α+ cDCs, pDCs, and GM-CSF bone marrow-derived DCs)
and different stimuli (in vivo injection of polyIC, in vivo injection of
STAg, in vitro stimulation with polyIC or LPS). The data are shown as
a heatmap representing the Log2 fold change in the expression of each
gene in stimulated as compared with unstimulated DCs. Values > = 1
are shown in yellow and values < = −1 in blue. For each activation
condition, data shown are from two independent replicates from two
different experiments.
compiling all GSEA performed, 72 genes were significantly upreg-
ulated, and 58 genes downregulated, in mature DCs in more than
80% of the 18 different experimental conditions studied, irre-
spective of stimuli, DC subsets and host species (“core UP” and
“core DOWN” genes listed in Table 2 and Supporting Information
Table 1). Ingenuity Pathway analysis showed that the genes upreg-
ulated in mature DCs were associated with Interferon Signaling
(p = 1.26 × 10−8), NFκB Signaling (p = 1.55 × 10−4), DC Mat-
uration (p = 1.82 × 10−6), Communication between Innate and
Adaptive Immune Cells (p= 4.68× 10−6), Inflammatory Response
(p = 1.53 × 10−13), Antimicrobial Response (p = 6.97 × 10−13),
Hematological System Development and Function (p = 1.16 ×
10−20), Cellular Growth and Proliferation (p = 1.16 × 10−20),
and Cell Death and Survival (p = 3.77 × 10−14). Fewer anno-
tations were found enriched for the genes downregulated and
with much lower statistical significance, such as Notch Signaling
(p = 8.32 × 10−3) and Hematological System Development and
Function (p = 6.76 × 10−5). Finally, using in silico cis-regulatory
C© 2013 The Authors. European Journal of Immunology published by
Wiley-VCH Verlag GmbH & Co. KGaA Weinheim.
www.eji-journal.eu
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Table 1. Microarray data used.
GEO IDa) Cell typesb) Organismc) Stimulid) Time pointse)
GSE21491f) CD8α+ cDCs, CD11b+
cDCs, pDCs, NK cells,
B cells
M. musculus MCMV v70 K181 36 h
GSE45365f) CD8α+ cDCs, CD11b+
cDCs, NK cells, CD8+
T cells, B cells
M. musculus MCMV v70 K181 36 h
GSE39556f) CD8α+ cDCs M. musculus Poly(I:C) 6 h
GSE15907 CD103+CD11b− DCs M. musculus Poly(I:C) Not available
GSE7831 pDCs M. musculus CpG 1826; influenza PR8 4 h
GSE17721 BMDCs M. musculus CpG; LPS; Pam; Poly(I:C); Grd 4 h
GSE10147 pDCs H. sapiens IL3+CpG 18 h
GSE14000 MoDCs H. sapiens LPS 4 h
GSE14816 MoDCs H. sapiens HCMV TB40E Not available
GSE2706 MoDCs H. sapiens LPS; R848; LPS+R848 8 h
a)Dataset record number in the Gene Expression omnibus (GEO) database.
b)Immune cell types studied. MoDCs: human monocyte-derived DCs, derived in vitro in GM-CSF and IL-4; BMDCs: mouse DCs derived in vitro in
GM-CSF bone marrow cultures.
c)Source organism for the DCs, human (Homo sapiens) or mouse (Mus musculus).
d)Stimuli used to mature the DCs.
e)Duration of the stimulation before cell harvest for microarray analysis.
f) In-house data.
sequence analyses, we observed a significant enrichment of tran-
scription factor binding sites (TFBS) for NF-κB, ISGF3, IRF8, and
IRF7 in the genes upregulated in mature DCs in more than 80% of
the conditions examined (Table 3). To functionally test whether
a significant proportion of the “core UP” genes with predicted
TFBS for ISGF3 or IRF7 required cell-intrisinc IFN-I signaling
in DC for their induction, we compared their expression in WT
versus Ifnar1−/− cDCs from mixed bone marrow chimeric mice.
Most of the genes with predicted regulation by IFN-I signaling
did require an intact IFN-I receptor in cDCs for their induction
duringMCMV infection (Supporting Information Table 1). Finally,
we investigated to which extent the “core UP” gene expression
program from mature DC was specific to the activation of these
cells as compared with shared responses with other immune cell
types, by analyzing its expression in B cells, NK cells, and CD8+
T cells isolated from the same MCMV-infected or control animals.
GSEA analysis showed a significant induction of the “core UP”
gene set in all the a cell types examined as compared with their
quiescent counterparts, not only in B cells but also in NK cells
and CD8+ T cells. However, when comparing a cell types with
one another, the “core UP” gene set was significantly induced to
higher levels in each activated DC subset as compared with each
activated lymphocyte subset (Supporting Information Fig. 4). An
analysis of individual genes showed that several genes were con-
sistently induced to a higher level in DCs as compared with the
other immune cell types examined, including B lymphocytes (Sup-
porting Information Fig. 5 representative genes in panel  and
Supporting Information Fig. 6 cluster ). Most of the genes that
reached similar levels in activated DCs and in at least another of
the cell types examined strongly depended on cell-intrinsic IFN-I
signaling for their induction (Supporting Information Fig. 5 rep-
resentative genes in panel  and Supporting Information Fig. 6
cluster) and were generally induced to much lower levels in NK
cells as previously reported [33].
Discussion
The goal of the present study was to examine the extent and
the specificity of the genetic reprogramming of DC subsets dur-
ing a viral infection in vivo, to compare the responses between
these cell types, and to investigate which signals instruct them.
A major aim was to determine whether different DC subsets
respond to infection mostly by the modulation of subset-specific
gene networks underlying their proposed functional specializa-
tion, or whether all DC subsets also share a major transcriptional
response.
For the first time to the best of our knowledge, we estab-
lished that the maturation of spleen-resident DC subsets during
a viral infection arose from widespread common changes in their
gene expression programs not only in pDCs but also in CD8α+
and CD11b+ cDCs which were much more profoundly reshaped
than anticipated. This partial convergence of the gene expres-
sion programs of all the three spleen DC subsets during MCMV
infection likely underlies the convergence of their morphological
and functional properties as previously reported [25, 26]. How-
ever, despite the extensive reprogramming of their gene expres-
sion programs, each DC subset maintained its own cell-type iden-
tity even at the mature stage at 36 hours after MCMV infection.
Many of the genes specifically expressed in q pDCs as compared
with many other leukocyte types were still expressed to much
higher levels in a pDCs than in a cDCs, even if they were decreased
as compared with those in q pDCs, including the genes cod-
ing for the transcription factors E2–2 and Runx2 and for the
C© 2013 The Authors. European Journal of Immunology published by
Wiley-VCH Verlag GmbH & Co. KGaA Weinheim.
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Figure 4. Bioinformatics analysis unraveling a core gene expression
program associated with DC maturation conserved between mouse
and human irrespective of the microbial stimuli and of the DC sub-
sets studied. GSEA for the Genesets modulated in DC subsets during
MCMV infection applied to various public microarray datasets. Gene-
Sets correspond to the different areas of the Venn diagrams in Figure 2.
Pair-wise comparisons were performed to assess enrichment of these
GeneSets between stimulated versus control cell cultures. The legend
is the same as for Figure 1C. The GEO datasets used are listed in Table
1. For each condition, data are shown from pooled replicates of at least
two independent experiments.
specific membrane markers, Siglech and Ccr9. Similarly,
a CD11b+ cDCs and a CD8α+ cDCs also kept the expression of
their respective specific gene signature defined under steady-state
conditions [4]. Thus, contrary to what had been proposed [27],
the fate of DC subsets during viral infection in vivo cannot be
strongly opposed: the changes induced upon maturation are as
profound in cDCs as in pDCs, and at least as important as ontogeny
in defining the identity of activated DC subsets. In other words,
cDCs are as versatile as pDCs since both subsets undergo major
and overlapping changes in their gene expression programs upon
maturation.
We generalized our study to other DC subsets and conditions
of stimulations in both mouse and human. Upon maturation, all
mouse and human DC subsets underwent a profound and overlap-
ping genetic reprogramming. We identified 130 genes regulated
upon DC maturation irrespective of stimuli and DC subsets and
conserved between mouse and human. Their regulatory regions
were enriched for putative transcription factor binding sites for
ISGF3, IRFs, and NF-κB. Hence, DC maturation must be univer-
sally driven by the modulation of a core set of genes controlled by
NF-κB, IFN-I, and IFN-γ signaling, in a conserved manner across
DC subsets, stimuli, and mammals. In addition to Cd80 and Cd86,
several other genes were induced to higher levels in cDC subsets
than in B lymphocytes, CD8+ T cells and NK cells responding to the
same infection in vivo: Tnfsf9, Il6, Cxcl9, Traf1, Marcksl1, Pla1a,
Clic4, Il15, and Tmcc3. These genes are therefore likely to criti-
cally contribute conferring to mature DCs their primary specific
functions, the ability to prime na¨ıve T cells, and to polarize them
toward specific functions. While the other genes induced in all DC
subsets under all conditions of stimulation were also induced to
similar expression levels at least in activated B cells, they are still
likely to modulate DC functions. Thus, we believe that our study
provides a unique resource for future investigations to continue
deciphering the molecular mechanisms modulating DC biology.
DC functional plasticity must arise from the superimposition to
this core activation pathway of cell subset- and stimuli-specific
modules determining in particular the nature of the downstream
functional polarization of T cells. The lack of very significant or
informative annotations for the genes induced specifically in par-
ticular DC subsets upon MCMV infection in vivo emphasizes the
need of further studies to better understand the molecular and
cellular bases of DC subset-specific functions.
Materials and methods
Mice, infection, and in vivo stimulations
8–12 week-old C57BL/6J mice were purchased from Charles River
Laboratories and bred at the Centre d’Immunologie de Marseille
Luminy (CIML), Marseille, France. Infections were performed by
ip injection of salivary gland-extracted MCMV v70 K181 strain
(5 × 104 PFU for C57BL/6 animals and 104 PFU for mixed
bone marrow chimera mice). 100 μg polyIC or 20 μg STAg were
injected iv. Spleen were harvested at 36 hours post-MCMV infec-
tion, 3 hours post-polyIC injection, and 12 hours post-STAg injec-
tion. Spleen cells were purified as described [4,33]. Experiments
were conducted in accordance with institutional guidelines for
animal care and use (French Provence Ethical Committee Proto-
cols no. 04/2005, 11-09/09/2011, and US Office of Laboratory
Animal Welfare Assurance A5665–01).
Cell sorting and mRNA preparation
Each cell type studied was sorted to over 98% purity (not shown)
by flow cytometry using an FACSAria (BD Bioscience) as previ-
ously reported [4,33]. pDCswere sorted as CD19−, CD3−, NK1.1−,
CD11b−, 120G8high, CD11cint cells. cDCs were sorted as CD19−,
CD3−, NK1.1−, 120G8−/low, CD11chigh and Ly6C−/low/intCD11b+,
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Table 2. List of the genes commonly regulated across DC subsets, stimuli, mouse, and human.
Change upon DC maturation
UP DOWN
Differential expression
frequencya)
Human Mouse
6/6 12/12 CCL2, CCL4, CFLAR, CXCL10,
GADD45B, GCH1, MARCKSL1,
RGS1, RIPK2
CERK, IL16, LYL1, MAPK14, MAST3,
MXD4, RAMP1, RCBTB2, TOP2B
6/6 11/12 CD38, GPD2, IFI44, IFIH1, IFIT2, IFIT3,
IL15RA, ISG20, MX1, OASL, PML,
RSAD2, SERPINB9, TDRD7
CAT, EXOSC5, FES, IFNGR1, INPP5D,
LAT2, MICAL1, MYCL1, TK2, CRTAP,
CRYL1, FUCA1, TM6SF1
6/6 10/12 CD80, CXCL9, IRF1, OAS2, RTP4,
SOS1, STAT1, TAP1, TNFSF10
–
5/6 12/12 CD200, CD86, CLIC4, DNAJA2, IL6,
PELI1, REL, SDC4, TANK, TLK2,
TMCC3, TNFAIP3, TNFSF9, TRAF1
GLTP, GRK6, HAGH, HMHA1, PDLIM2,
PPM1M, PRKDC, RGS18, SFXN3,
VPS26B
5/6 11/12 AZI2, B3GNT2, DUSP2, EIF2AK2,
GBP2, IL15, IL2RA, NFKBIA, NT5C3,
PARP9, PI4K2B, PLA1A, RBBP8,
STAT2, TRIM21, UBE2L6, XRN1
ADD3, ARHGAP18, BNIP3L, CYB5R1,
HACL1, MFNG, PNPO, SCARB1,
ST6GAL1, XPC, ZMAT3
5/6 10/12 CCDC50, CFB, JDP2, LTA, NCK2, NMI,
PTGS2, TNFSF4, ZNF281
APEX1, DHRS1, GLUD1, HEXA, HEXB,
IDH1, IMPA2, MPHOSPH9, NCOR2,
RFNG, RGL2, SMPD2, TRIT1, WDR81,
XPOT
a)Number of experimental conditions where the genes are found to be significantly modulated in mature DCs as compared to immature DCs/total
number of experimental conditions tested.
Table 3. TFBS enrichment in the core gene sets modulated upon DC
maturation.
Expressiona) Matrixb) TFc) p-Valued)
UP IRF Q6 Irf1; Irf10 <10−6
UP IRF7 01 Irf7a <10−6
UP NFKB C;
NFKAP-
PAB65 01
NFKAPPAB 01;
NFKB Q6
NFkB <10−6
UP CREL 01 C-rel <10−6
UP ISRE 01 Isgf3 7 × 10−6
UP ICSBP Q6 Irf8 9 × 10−6
UP NFKB Q6 01 NFkB 1.3 × 10−5
UP IRF1 01;
IRF Q6 01
Irf1; Irf10 <4.7 × 10−5
UP IRF2 01 Irf2 4.7 × 10−5
DOWN USF2 Q6 Usf2a 4 × 10−6
DOWN USF C Usf1 9 × 10−6
DOWN NMYC 01 N-myc 2 × 10−5
DOWN MYC Q2 Myc 4.4 × 10−5
a)Expression pattern. UP: induced in a_DCs as compared with q_DCs;
DOWN: repressed in a_DCs as compared with q_DCs.
b)Name of the TFBS matrix as defined in TRANSFAC.
c)Transcription factor that could bind to the matrix.
d)p-Value resulting from the statistical assessment of the enrich-
ment of the matrix in the set of test sequences as compared
to the set of control sequences as calculated by using PAASTA
(http://trap.molgen.mpg.de/PASTAA.htm).
or CD8α+. Upon MCMV infection, Ly6C is upregulated to some
extent on CD11b+ DCs but not to the high levels found on mono-
cytes or MoDCs (not shown). Hence, for the purification of spleen
CD11b+ cDCs, we excluded Ly6Chigh cells to avoid contamination
with monocytes or MoDCs. In consistency, the sorted CD11b+
cDCs showed no or only low expression of the Ly6c1, Csf3r,
Tlr8, Cd14, and Ccr2 monocyte genes reported to be expressed
to higher levels in spleen monocyte-derived CD11b+Esamlow
DCs [34]. Duplicate or triplicate samples were generated from
independent experiments using pooled spleens of untreated,
MCMV-infected, poly(I:C)-injected or STAg-injected mice. High
quality total RNA was prepared as described [33].
Microarray experiments and analyses
Microarray and real-time PCR experiments were performed,
processed, and analyzed as described [33]. Genes differen-
tially expressed between quiescent and activated DC sub-
sets (Fig. 2A and B) in a statistically significant manner
(false discovery rate ≤0.05) were identified using VAMPIRE
(http://sasquatch.ucsd.edu/vampire/), a procedure based on a
mathematical modeling of the data allowing robust statistical
analysis of duplicates [35] and further selected based on a
fold change ≥2 as previously published [33]. Datasets have
been deposited in the GEO database under reference numbers
GSE21491, GSE45365, and GSE39556. The core gene signature
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modulated in>80% of the 18 activation conditions was generated
as follows. We applied GSEA to the 18 activation conditions, using
as GeneSets the lists of genes modulated in DC subsets during
MCMV infection (Fig. 4). On top of the normalized enrichment
score and of the significance of the enrichment (false discovery
rate), GSEA also provides as an output the leading edge that cor-
responds to the list of genes that contribute the most to the enrich-
ment score [30]. We selected the genes present in at least 10/12
murine and 5/6 human leading edges for each of the GeneSets,
and made the union of all these lists for the upregulated genes
on one hand, and for the downregulated genes on the other hand
(Supporting Information Table 1).
Real-time PCR experiments and analyses
Real-time PCR experiments and analyses were performed as
described [33], using the RT2ProfilerTMPCR Array System with
custom-made arrays (SABiosciences).
In silico cis-regulatory sequence analysis
TFBS enrichment was assessed on the −400 to +400 nt relative
to promoter TSS using pattern matching (PASTAA and CLOVER)
and motif discovery (MEME) algorithms as previously described
[33].
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